Drug Profile
Prod 4
Alternative Names: Prod-4Latest Information Update: 28 Jan 2021
Price :
$50
*
At a glance
- Originator Zydus Cadila
- Class Antineoplastics; Thrombolytics
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- No development reported Cancer; Myocardial infarction
Most Recent Events
- 28 Jan 2021 No recent reports of development identified for research development in Cancer in India
- 28 Jan 2021 No recent reports of development identified for research development in Myocardial-infarction in India
- 01 Dec 2016 Early research in Cancer in India (Unspecified route) before December 2016